Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus

被引:29
作者
Nahal, Simran Kaur [1 ]
Selmi, Carlo [2 ,3 ]
Gershwin, M. Eric [1 ]
机构
[1] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Humanitas Res Hosp, Div Rheumatol & Clin Immunol, Milan, Italy
[3] Univ Milan, Dept Biomed Sci & Translat Med, Milan, Italy
关键词
Rheumatology; Infertility; Miscarriage; Teratogenicity; Anti-phospholipid; 3; ETHNIC-GROUPS; CONGENITAL HEART-BLOCK; ANTIPHOSPHOLIPID SYNDROME; NEONATAL LUPUS; FETAL OUTCOMES; CARDIAC MANIFESTATIONS; DISEASE-ACTIVITY; RISK-FACTORS; ANTI-RO/SSA; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.jaut.2018.07.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic lupus erythematosus (SLE) primarily affects women of childbearing age. One of the major changes in SLE focuses on the timing of a successful pregnancy. In the past, pregnancy was strongly discouraged in SLE, especially in the presence of risk factors such as nephritis, use of immunosuppressive therapies, or positivity of specific autoantibodies such as anti-phospholipids and anti-Ro/SSA, La/SSBA. Thanks to our better knowledge on the disease and management, pregnancy success rates in SLE patients have significantly improved care by the a multidisciplinary team which fosters a successful pregnancy with minimal complications for the mother and fetus when the disease is inactive or in remission. This approach is based on a counseling phase before pregnancy, to assess SLE activity phase, specific medications, risk factors, and continues through pregnancy and lactation with significantly improved pregnancy outcomes. Further, we can now better define the risk of disease flares during pregnancy based on a better understanding of the changes in maternal immunity and its relationship with SLE-associated autoimmunity and chronic inflammation. There is wide consensus that women with SLE can have successful pregnancies as long as conception is planned in a phase of inactive disease, and when the patient is closely managed by a rheumatologist, high-risk OB/GYN, neonatologist, and other medical specialists as indicated. Preconception counseling is essential to assess the risk of both fetal and maternal complications as well as identify life-threatening contraindications. Particular attention should be used in those SLE cases that have nephritis, APS or positivity for aPL, pulmonary hypertension, and positive anti-Ro/SSA or anti-La/SSB antibodies. In conclusion, the use of specific guidelines on the management of SLE before and during pregnancy and lactation, and a better understanding of the use of immunosuppressive therapies have significantly increased pregnancy success.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 130 条
  • [1] Alarcón GS, 2001, ARTHRIT RHEUM-ARTHR, V45, P191, DOI 10.1002/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO
  • [2] 2-2
  • [3] Alarcón GS, 1998, ARTHRITIS RHEUM-US, V41, P1173, DOI 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO
  • [4] 2-A
  • [5] Alarcón GS, 1999, ARTHRIT CARE RES, V12, P267, DOI 10.1002/1529-0131(199908)12:4<267::AID-ART5>3.0.CO
  • [6] 2-9
  • [7] Alarcón GS, 2001, ARTHRITIS RHEUM, V44, P2797, DOI 10.1002/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO
  • [8] 2-9
  • [9] Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort
    Alarcón, GS
    Friedman, AW
    Straaton, KV
    Moulds, JM
    Lisse, J
    Bastian, HM
    McGwin, G
    Bartolucci, AA
    Roseman, JM
    Reveille, JD
    [J]. LUPUS, 1999, 8 (03) : 197 - 209
  • [10] Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review
    Alijotas-Reig, Jaume
    Esteve-Valverde, Enrique
    Ferrer-Oliveras, Raquel
    Llurba, Elisa
    Maria Gris, Josep
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 53 (01) : 40 - 53